FDA 483 - Micro Labs Limited - February 09, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Micro Labs Limited received a Form 483 with significant observations related to quality control, equipment cleaning, laboratory controls, and employee training. The firm released drug products with valid Out-of-Specification results, failed to adequately clean manufacturing equipment leading to potential cross-contamination, and delayed reporting Field Alert Reports for over 1.5 years. These issues indicate a systemic breakdown in quality oversight and adherence to cGMP regulations, posing risks to drug product safety and purity in the US market.
ID · b85fe235-26a2-4849-948b-1461f62badc7